The anti-malaria drug artesunate inhibits cigarette smoke and ovalbumin concurrent exposure-induced airway inflammation and might reverse glucocorticoid insensitivity

Int Immunopharmacol. 2015 Dec;29(2):235-245. doi: 10.1016/j.intimp.2015.11.016. Epub 2015 Nov 14.

Abstract

Background: The anti-malaria drug artesunate has been shown to attenuate experimental allergic asthma via inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. This study was to further determine the effects of artesunate on cigarette smoke and ovalbumin (OVA) concurrent exposure-induced airway inflammation, the related mechanism, and glucocorticoid insensitivity.

Methods and results: In vivo: Female BALB/c mice concurrently exposed to cigarette smoke and OVA developed mixed eosinophilic and neutrophilic airway inflammation. Airway hyper-responsiveness, total and differential cell counts, and pro-inflammatory cytokine levels (interleukin (IL)-4, IL-8, IL-13 and tumor necrosis factor (TNF)-α) in bronchoalveolar lavage fluid (BALF) were measured. Lung tissue sections were stained for histological analysis, and proteins were extracted for Western blotting. Artesunate reduced methacholine-induced airway hyper-responsiveness, suppressed pulmonary inflammation cell recruitment and IL-4, IL-8, IL-13 and TNF-α levels, selectively inhibited PI3Kδ/Akt pathway, and restored HDAC2 activity. In vitro: BEAS-2B cells were exposed to cigarette smoke extract (CSE) for 6h and then stimulated with TNF-α overnight. Glucocorticoid sensitivity was evaluated by the inhibition of TNF-α-induced IL-8 production by dexamethasone. CSE reduced the effects of dexamethasone on TNF-α-induced IL-8 production in BEAS-2B cells, while artesunate reversed CSE-induced glucocorticoid insensitivity and restored HDAC2 deactivation induced by CSE.

Conclusion: Artesunate ameliorated cigarette smoke and OVA concurrent exposure-induced airway inflammation, inhibited the PI3Kδ/Akt pathway, restored HDAC2 activity, and reversed CSE-induced glucocorticoid insensitivity in BEAS-2B cells. These findings indicate that artesunate might play a protective role in asthma induced by cigarette smoke and glucocorticoid insensitivity.

Keywords: Airway inflammation; Artesunate; Glucocorticoid; HDAC2; PI3Kδ; Severe asthma.

MeSH terms

  • Animals
  • Antimalarials / therapeutic use*
  • Artemisinins / therapeutic use*
  • Artesunate
  • Asthma / chemically induced
  • Asthma / prevention & control
  • Bronchial Hyperreactivity / immunology
  • Bronchoalveolar Lavage Fluid / cytology
  • Cell Line
  • Cytokines / metabolism
  • Dexamethasone / pharmacology
  • Drug Resistance / drug effects
  • Eosinophils / drug effects
  • Eosinophils / immunology
  • Female
  • Glucocorticoids / pharmacology*
  • Inflammation / chemically induced*
  • Inflammation / prevention & control*
  • Lung / pathology
  • Mice
  • Mice, Inbred BALB C
  • Nicotiana*
  • Ovalbumin / antagonists & inhibitors*
  • Ovalbumin / toxicity*
  • Respiratory Tract Diseases / chemically induced*
  • Respiratory Tract Diseases / prevention & control*
  • Smoke / adverse effects*

Substances

  • Antimalarials
  • Artemisinins
  • Cytokines
  • Glucocorticoids
  • Smoke
  • Artesunate
  • Dexamethasone
  • Ovalbumin